Endocyte, Inc. (ECYT) Appoints Torsten Hoof, Ph.D., as Vice President and General Manager, Europe, and Ulf Staginnus as Executive Director, Head Market Access and Pricing, Europe
4/25/2013 11:20:31 AM
More...
|
Endocyte, Inc. (ECYT) Announces First Quarter 2013 Earnings Conference Call
4/19/2013 11:16:25 AM
More...
|
Endocyte, Inc. (ECYT) to Present at the Future Leaders in the Biotech Industry Conference
4/1/2013 10:24:06 AM
More...
|
Endocyte, Inc. (ECYT) to Webcast Investor and Analyst Day in New York City
3/18/2013 12:40:45 PM
More...
|
Endocyte, Inc. (ECYT) to Advance Development of EC1069, a PSMA-Targeted Small Molecule Drug Conjugate Therapy for Prostate Cancer
1/30/2013 9:37:07 AM
More...
|
Endocyte, Inc. (ECYT) Selects Medidata Solutions, Inc. Clinical Cloud to Support Oncology Studies
12/14/2012 10:21:27 AM
More...
|
Endocyte, Inc. (ECYT) to Present at Upcoming Healthcare Conferences
11/7/2012 9:36:37 AM
More...
|
Endocyte, Inc. (ECYT) Reports Third Quarter 2012 Financial Results and Business Update
11/2/2012 7:41:55 AM
More...
|
Endocyte, Inc. (ECYT) Announces Third Quarter 2012 Earnings Conference Call
10/26/2012 6:44:43 AM
More...
|
Endocyte, Inc. (ECYT) Release: Data Published Identify the Folate Receptor as a Potential Biomarker for Targeted Therapies in a Majority of Lung Cancers
10/12/2012 9:38:40 AM
More...
|
|